Dr. Sostek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 King of Prussia Rd
Penn Medicine at Radnor
Radnor, PA 19087Phone+1 610-902-1544
Education & Training
- University of Florida Shands HospitalTraining, Antroduodenal and small bowel manometry , 1997 - 1997
- GastroenterologyFellowship, 1991 - 1993
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986, MD, Alpha Omega Alpha; Hewlett Packard Award
- Middlebury CollegeBachelor of Arts, 1976 - 1980
Certifications & Licensure
- CA State Medical License 1987 - Present
- PA State Medical License 1998 - 2024
- MA State Medical License 1987 - 2001
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2006
Clinical Trials
- An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium Start of enrollment: 2006 Oct 01
- A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) Start of enrollment: 2007 Dec 01
- Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsTreatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.Lynn R. Webster, Ulysses Diva, Raj Tummala, Mark Sostek
Pain Practice. 2018-04-01 - 10 citationsCardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.William B. White, Peter R. Kowey, Ulysses Diva, Mark Sostek, Raj Tummala
Journal of Cardiovascular Pharmacology and Therapeutics. 2018-03-04 - 32 citationsPharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation.Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza, Michael A. Eldon
The Journal of Pharmacology and Experimental Therapeutics. 2017-03-23
Books/Book Chapters
Abstracts/Posters
- Is the Prevalence of Moderate to Severe Erosive Oesophagitis (EE) More Common than we think? A Demographic Characterisation of Patients with Los Angeles Grade C...Fennerty MB, Johanson J, Hwang C, Hoyle P and Sostek M, United European Gastroenterology Week
- Esomeprazole provides highly effective acid control that is equally wll maintained during sleep and active periods.Katz PO, Castell DO, Chen Y and Sostek MB, Am J Gastro
- Integrated Gastric Acidity to Evaluate Acid Suppression with PPI therapy: a five way crossover comparison.Miner PB, Chen Y and Sostek MB, Gastroenterology
- Join now to see all
Press Mentions
- Northside Park Gastroenterology and Endoscopy Center Owner Dr. Michael Sue to Retire — 4 InsightsJanuary 8th, 2018
- 5 Predictions on GI in 2018January 8th, 2018
- OrphoMed Taps GI Expert Dr. Mark Sostek for CMO Position — 3 InsightsJanuary 5th, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: